{"id":48009,"date":"2022-09-06T16:01:52","date_gmt":"2022-09-06T14:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/"},"modified":"2022-09-06T16:01:52","modified_gmt":"2022-09-06T14:01:52","slug":"trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/","title":{"rendered":"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research"},"content":{"rendered":"
\n

CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee<\/a> CEO Matt Walz<\/a> has been named to the 2022 PharmaVoice 100 <\/a>\u2014 an annual list that recognizes the most inspiring people in the life-sciences industry \u2013 for his work to increase access, diversity, and efficiency in clinical research.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWith the number of clinical trials over the next five years requiring 125 million patients<\/a>, it is imperative that we democratize access to clinical research with a more patient-centric approach,\u201d says Walz, who has been bringing disruptive software innovations to the life sciences industry for more than two decades. \u201cAt Trialbee, we are drastically improving global patient recruitment and enrollment by operationalizing real-world data (RWD), simplifying the patient journey and reducing the burden of enrolling patients for sites.\u201d\n<\/p>\n

\nIn 2021, Walz helped Trialbee launch Trialbee Honey\u2122, its flagship SaaS-based product and the first solution to track and measure all global recruitment activities while optimizing enrollment timelines through real-time analytics. Trialbee\u2019s purpose-built platform uses data-driven insights to improve patient enrollment at global scale.\n<\/p>\n

\nWalz\u2019s inspired, hands-on approach has helped Trialbee quadruple sales and grow the employee base to span across eight countries while delivering global recruitment projects with eight of the top 10 global pharmaceutical companies. Trialbee\u2019s innovative technology and offerings are available globally in over 48 countries, with active engagements in studies in 24 countries with major CROs, large pharmaceutical companies, and mid-sized biotechs.\n<\/p>\n

\n\u201cIt is always an honor to showcase these inspiring individuals, whose leadership over the past 18 months has been more important than ever to make sure their teams, the patients they serve, and their organizations continue to excel at the highest levels possible,\u201d said Taren Grom, PharmaVoice Editor in Chief Emeritus.\n<\/p>\n

\nPharmaVoice100 selects honorees from a pool of nominations submitted by readers and evaluated by the PharmaVoice team. This year\u2019s honorees include Legacy Leaders, Tech Wizards, Innovators, Disrupters, Entrepreneurs, and DE&I Champions.\n<\/p>\n

\nTo recognize these honorees and discuss the challenges faced across the life-sciences industry, join PharmaVoice on Sept. 15 for a free, full-day virtual event<\/a>.\n<\/p>\n

\nAbout Trialbee<\/b>\n<\/p>\n

\nTrialbee is the leading global data and technology platform for patient recruitment and enrollment in clinical trials. Trialbee Hive\u2122 operationalizes real world data (RWD) and applies data science to find patients globally. Trialbee Honey\u2122 simplifies the journey into clinical research for patients, reduces the burden of enrolling patients for sites and provides real-time, data-driven insights to sponsors and CROs so they can optimize enrollment timelines. Partnering with sponsors, CROs, and virtual\/decentralized sites, and software providers, Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical trial populations. We are the smartest way to match and enroll patients for your clinical trial. For more information, visit http:\/\/www.trialbee.com<\/a> or contact us at solutions@trialbee.com<\/a>.\n<\/p>\n

\nAbout PharmaVoice<\/b>\n<\/p>\n

\nPharmaVoice is a leading industry publication operated by Industry Dive. Our stories deliver the most important voices and ideas in the life sciences to industry leaders.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt McLoughlin
\n
Gregory FCA (for Trialbee)
\n
610.228.2123
\n
Matt@GregoryFCA.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee CEO Matt Walz has been named to the 2022 PharmaVoice 100 \u2014 an annual list that recognizes the most inspiring people in the life-sciences industry \u2013 for his work to increase access, diversity, and efficiency in clinical research. \u201cWith the number of clinical trials over the next five … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48009","6":"format-standard","7":"category-industry"},"yoast_head":"\nTrialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee CEO Matt Walz has been named to the 2022 PharmaVoice 100 \u2014 an annual list that recognizes the most inspiring people in the life-sciences industry \u2013 for his work to increase access, diversity, and efficiency in clinical research. \u201cWith the number of clinical trials over the next five ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T14:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220906005384\/en\/1561642\/21\/Trialbee-Logo_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research\",\"datePublished\":\"2022-09-06T14:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/\"},\"wordCount\":505,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005384\\\/en\\\/1561642\\\/21\\\/Trialbee-Logo_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/\",\"name\":\"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005384\\\/en\\\/1561642\\\/21\\\/Trialbee-Logo_%281%29.jpg\",\"datePublished\":\"2022-09-06T14:01:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005384\\\/en\\\/1561642\\\/21\\\/Trialbee-Logo_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005384\\\/en\\\/1561642\\\/21\\\/Trialbee-Logo_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/","og_locale":"en_US","og_type":"article","og_title":"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research - Pharma Trend","og_description":"CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee CEO Matt Walz has been named to the 2022 PharmaVoice 100 \u2014 an annual list that recognizes the most inspiring people in the life-sciences industry \u2013 for his work to increase access, diversity, and efficiency in clinical research. \u201cWith the number of clinical trials over the next five ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-06T14:01:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220906005384\/en\/1561642\/21\/Trialbee-Logo_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research","datePublished":"2022-09-06T14:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/"},"wordCount":505,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005384\/en\/1561642\/21\/Trialbee-Logo_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/","url":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/","name":"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005384\/en\/1561642\/21\/Trialbee-Logo_%281%29.jpg","datePublished":"2022-09-06T14:01:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220906005384\/en\/1561642\/21\/Trialbee-Logo_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220906005384\/en\/1561642\/21\/Trialbee-Logo_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/trialbee-ceo-matt-walz-named-to-pharmavoice100-for-innovation-in-clinical-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48009"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48009\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}